Nitric oxide and DOPAC-induced cell death: From GSH depletion to mitochondrial energy crisis

Molecular and Cellular Neuroscience

Volumn 48, Issue 1, 2011, Pages 94-103

  Nunes, Carla ^a   Barbosa, Rui M ^a   Almeida, Leonor ^a   Laranjinha, João ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

DOPAC; Glutathione; Mitochondria; Nitric oxide; Parkinson's disease

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ACETYLCYSTEINE; FREE RADICAL; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE ETHYL ESTER; NITRIC OXIDE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; MITOCHONDRION ENERGY CRISIS; MODULATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SIGNAL TRANSDUCTION;

3,4-DIHYDROXYPHENYLACETIC ACID; ACETYLCYSTEINE; ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; DOPAMINE; ELECTRON SPIN RESONANCE SPECTROSCOPY; ELECTRON TRANSPORT COMPLEX I; FREE RADICALS; GLUTATHIONE; MITOCHONDRIA; NITRIC OXIDE; NITRIC OXIDE DONORS; OXIDATION-REDUCTION; PARKINSON DISEASE; PC12 CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REACTIVE OXYGEN SPECIES; S-NITROSO-N-ACETYLPENICILLAMINE;

EID: 79960921750     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2011.06.009     Document Type: Article

References (66)

1. Alexander T., Sortwell C.E., Sladek C.D., Roth R.H., Steece-Collier K. Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors. Cell Transplant. 1997, 6:309-315.
2. Antunes F., Han D., Rettori D., Cadenas E. Mitochondrial damage by nitric oxide is potentiated by dopamine in PC12 cells. Biochim. Biophys. Acta 2002, 1556:233-238.
3. Antunes F., Nunes C., Laranjinha J., Cadenas E. Redox interactions of nitric oxide with dopamine and its derivatives. Toxicology 2005, 208:207-212.
4. Arteel G.E., Briviba K., Sies H. Protection against peroxynitrite. FEBS Lett. 1999, 445:226-230.
5. Barker J.E., Bolanos J.P., Land J.M., Clark J.B., Heales S.J. Glutathione protects astrocytes from peroxynitrite-mediated mitochondrial damage: implications for neuronal/astrocytic trafficking and neurodegeneration. Dev. Neurosci. 1996, 18:391-396.
6. Bergeron L., Perez G.I., Macdonald G., Shi L., Sun Y., Jurisicova A., Varmuza S., Latham K.E., Flaws J.A., Salter J.C., Hara H., Moskowitz M.A., Li E., Greenberg A., Tilly J.L., Yuan J. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 1998, 12:1304-1314.
7. Bindoff L.A., Birch-Machin M., Cartlidge N.E., Parker W.D., Turnbull D.M. Mitochondrial function in Parkinson's disease. Lancet 1989, 2:49.
8. Celli A., Que F.G., Gores G.J., LaRusso N.F. Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes. Am. J. Physiol. 1998, 275:G749-757.
9. Cook J.A., Wink D.A., Blount V., Krishna M.C., Hanbauer I. Role of antioxidants in the nitric oxide-elicited inhibition of dopamine uptake in cultured mesencephalic neurons. Insights into potential mechanisms of nitric oxide-mediated neurotoxicity. Neurochem. Int. 1996, 28:609-617.
10. Czerniczyniec A., Bustamante J., Lores-Arnaiz S. Dopamine enhances mtNOS activity: implications in mitochondrial function. Biochim. Biophys. Acta 2007, 1767:1118-1125.
11. Daveu C., Servy C., Dendane M., Marin P., Ducrocq C. Oxidation and nitration of catecholamines by nitrogen oxides derived from nitric oxide. Nitric Oxide 1997, 1:234-243.
12. Deneke S.M., Baxter D.F., Phelps D.T., Fanburg B.L. Increase in endothelial cell glutathione and precursor amino acid uptake by diethyl maleate and hyperoxia. Am. J. Physiol. 1989, 257:L265-271.
13. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Meth. 1986, 89:271-277.
14. Dringen R. Metabolism and functions of glutathione in brain. Prog. Neurobiol. 2000, 62:649-671.
15. Duda J.E., Giasson B.I., Chen Q., Gur T.L., Hurtig H.I., Stern M.B., Gollomp S.M., Ischiropoulos H., Lee V.M., Trojanowski J.Q. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am. J. Pathol. 2000, 157:1439-1445.
16. Filloux F., Townsend J.J. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp. Neurol. 1993, 119:79-88.
17. Garthwaite J., Boulton C.L. Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 1995, 57:683-706.
18. Gerlach M., Ben-Shachar D., Riederer P., Youdim M.B. Altered brain metabolism of iron as a cause of neurodegenerative diseases?. J. Neurochem. 1994, 63:793-807.
19. Giasson B.I., Duda J.E., Murray I.V., Chen Q., Souza J.M., Hurtig H.I., Ischiropoulos H., Trojanowski J.Q., Lee V.M. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000, 290:985-989.
20. Good P.F., Hsu A., Werner P., Perl D.P., Olanow C.W. Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 1998, 57:338-342.
21. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 1976, 73:2424-2428.
22. Gu M., Owen A.D., Toffa S.E., Cooper J.M., Dexter D.T., Jenner P., Marsden C.D., Schapira A.H. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. J. Neurol. Sci. 1998, 158:24-29.
23. Gukasyan H.J., Kannan R., Lee V.H., Kim K.J. Regulation of l-cystine transport and intracellular GSH level by a nitric oxide donor in primary cultured rabbit conjunctival epithelial cell layers. Invest. Ophthalmol. Vis. Sci. 2003, 44:1202-1210.
24. Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R.T., Beal M.F. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med. 1996, 2:1017-1021.
25. Hastings T.G., Lewis D.A., Zigmond M.J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:1956-1961.
26. Henchcliffe C., Beal M.F. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat. Clin. Pract. Neurol. 2008, 4:600-609.
27. Hissin P.J., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976, 74:214-226.
28. Hsu M., Srinivas B., Kumar J., Subramanian R., Andersen J. Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease. J. Neurochem. 2005, 92:1091-1103.
29. Janetzky B., Hauck S., Youdim M.B., Riederer P., Jellinger K., Pantucek F., Zochling R., Boissl K.W., Reichmann H. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci. Lett. 1994, 169:126-128.
30. Jenner P. Oxidative stress in Parkinson's disease and other neurodegenerative disorders. Pathol. Biol. (Paris) 1996, 44:57-64.
31. Jenner P., Dexter D.T., Sian J., Schapira A.H., Marsden C.D. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann. Neurol. 1992, 32(Suppl):S82-87.
32. Jha N., Jurma O., Lalli G., Liu Y., Pettus E.H., Greenamyre J.T., Liu R.M., Forman H.J., Andersen J.K. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J. Biol. Chem. 2000, 275:26096-26101.
33. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257.
34. Klivenyi P., Andreassen O.A., Ferrante R.J., Lancelot E., Reif D., Beal M.F. Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity. Neuroreport 2000, 11:1265-1268.
35. Laranjinha J., Cadenas E. Oxidation of DOPAC by nitric oxide: effect of superoxide dismutase. J. Neurochem. 2002, 81:892-900.
36. LaVoie M.J., Hastings T.G. Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss. J. Neurochem. 1999, 73:2546-2554.
37. Luperchio S., Tamir S., Tannenbaum S.R. NO-induced oxidative stress and glutathione metabolism in rodent and human cells. Free Radic. Biol. Med. 1996, 21:513-519.
38. Mann V.M., Cooper J.M., Krige D., Daniel S.E., Schapira A.H., Marsden C.D. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 1992, 115(Pt 2):333-342.
39. Martin H.L., Teismann P. Glutathione-a review on its role and significance in Parkinson's disease. FASEB J. 2009, 23:3263-3272.
40. Michel P.P., Hefti F. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 1990, 26:428-435.
41. Miura K., Ishii T., Sugita Y., Bannai S. Cystine uptake and glutathione level in endothelial cells exposed to oxidative stress. Am. J. Physiol. 1992, 262:C50-58.
42. Mizuno Y., Yoshino H., Ikebe S., Hattori N., Kobayashi T., Shimoda-Matsubayashi S., Matsumine H., Kondo T. Mitochondrial dysfunction in Parkinson's disease. Ann. Neurol. 1998, 44:S99-109.
43. Nunes C., Almeida L., Laranjinha J. Synergistic inhibition of respiration in brain mitochondria by nitric oxide and dihydroxyphenylacetic acid (DOPAC). Implications for Parkinson's disease. Neurochem. Int. 2005, 47:173-182.
44. Nunes C., Almeida L., Laranjinha J. 3,4-Dihydroxyphenylacetic acid (DOPAC) modulates the toxicity induced by nitric oxide in PC-12 cells via mitochondrial dysfunctioning. Neurotoxicology 2008, 29:998-1007.
45. Ochi T. Hydrogen peroxide increases the activity of gamma-glutamylcysteine synthetase in cultured Chinese hamster V79 cells. Arch. Toxicol. 1995, 70:96-103.
46. Perovic S., Pialoglou P., Schroder H.C., Pergande G., Muller W.E. Flupirtine increases the levels of glutathione and Bc1-2 in hNT (human Ntera/D1) neurons: mode of action of the drug-mediated anti-apoptotic effect. Eur. J. Pharmacol. 1996, 317:157-164.
47. Perry T.L., Yong V.W. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci. Lett. 1986, 67:269-274.
48. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., Dawson T.M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:4565-4571.
49. Ragan C., Wilson M., Darley-Usmar V., Lowe P. Subfractionation of mitochondria, and isolation of the proteins of oxidative phosphorilation. Mitochondria, a Practical Approach 1987, 79-112. IRL Press, London. V. Darley-Usmar, D. Rickwood, M. Wilson (Eds.).
50. Ranawat P., Bansal M.P. Apoptosis induced by modulation in selenium status involves p38 MAPK and ROS: implications in spermatogenesis. Mol. Cell Biochem. 2009, 330:83-95.
51. Rettori D., Tang Y., Dias L.C., Cadenas E. Pathways of dopamine oxidation mediated by nitric oxide. Free Radic. Biol. Med. 2002, 33:685-690.
52. Riederer P., Sofic E., Rausch W.D., Schmidt B., Reynolds G.P., Jellinger K., Youdim M.B. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 1989, 52:515-520.
53. Riederer P., Dirr A., Goetz M., Sofic E., Jellinger K., Youdim M.B. Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease. Ann. Neurol. 1992, 32:S101-104. Suppl.
54. Roskoski R., Roskoski L.M. Activation of tyrosine hydroxylase in PC12 cells by the cyclic GMP and cyclic AMP second messenger systems. J. Neurochem. 1987, 48:236-242.
55. Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 2001, 30:1191-1212.
56. Schapira A.H., Cooper J.M., Dexter D., Jenner P., Clark J.B., Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989, 1:1269.
57. Schapira A.H., Cooper J.M., Dexter D., Clark J.B., Jenner P., Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 1990, 54:823-827.
58. Schapira A.H., Mann V.M., Cooper J.M., Krige D., Jenner P.J., Marsden C.D. Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann. Neurol. 1992, 32(Suppl):S116-S124.
59. Segieth J., Fowler L., Whitton P., Pearce B. Nitric oxide-mediated regulation of dopamine release in the hippocampus in vivo. Neuropharmacology 2000, 39:571-577.
60. Stocchi V., Cucchiarini L., Magnani M., Chiarantini L., Palma P., Crescentini G. Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells. Anal. Biochem. 1985, 146:118-124.
61. Strack P.R., Frey M.W., Rizzo C.J., Cordova B., George H.J., Meade R., Ho S.P., Corman J., Tritch R., Korant B.D. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:9571-9576.
62. Watanabe Y., Kato H., Araki T. Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease. Metab. Brain Dis. 2008, 23:51-69.
63. Watson R.W., Rotstein O.D., Nathens A.B., Dackiw A.P., Marshall J.C. Thiol-mediated redox regulation of neutrophil apoptosis. Surgery 1996, 120:150-157. discussion 157-158.
64. Wegener G., Volke V., Rosenberg R. Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br. J. Pharmacol. 2000, 130:575-580.
65. Wu D., Cederbaum A. Glutathione depletion in CYP2E1-expressing liver cells induces toxicity due to the activation of p38 mitogen-activated protein kinase and reduction of nuclear factor-kappaB DNA binding activity. Mol. Pharmacol. 2004, 66:749-760.
66. Yokoyama H., Takagi S., Watanabe Y., Kato H., Araki T. Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice. J. Neural Transm. 2008, 115:831-842.